Repligen Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 5.09, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Repligen in Jun 30 2026 quarter, has decreased to 72 days, compared to 74 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 367 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1912 to 2597.

What is Receivable Turnover Ratio?
What is Repligen Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RGEN Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	0.48 %	2.81 %	18.25 %	15.46 %	27.35 %
Y / Y Revenue Change	11.93 %	14.83 %	18.12 %	21.91 %	14.81 %
Receivable Turnover Ratio (TTM)	5.09	4.96	4.83	4.82	4.75
RGEN's Total Ranking	# 2597	# 1912	# 2454	# 2593	# 2520
Accounts Receivable average collection period days	72	74	76	76	77
Seq. Receivable Change	4.06 %	-4.44 %	6.46 %	-5.09 %	6.47 %
Seq. Revenue Change	5.08 %	-1.85 %	4.82 %	3.53 %	7.8 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 38
Healthcare Sector	# 368
Overall Market	# 2597

Receivable Turnover Ratio Statistics
High	Average	Low
8.33	6.26	4.75
(Dec 31 2014)		(Jun 30 2025)

RGEN Company Profile • Back to RGEN Efficiency Comparisons • Compare RGEN Receivables Turnover Ratio to its Competitors

Financial Statements
Repligen's Accounts Receivable	$ 158 Millions	Visit RGEN's Balance sheet
Repligen's Sales TTM	$ 785 Millions	Visit RGEN's Income Statement
Sources of RGEN's Revenues		Visit RGEN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RGEN's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RGEN's Growth Rates	RGEN's Roa	RGEN's Inventory Turnover Ratio	RGEN's Dividend Comparisons
RGEN's Profitability Ratios	RGEN's Roi	RGEN's Asset Turnover Ratio	RGEN's Dividend Growth
RGEN's Valuation Ratios	RGEN's Roe	RGEN's Financial Strength Ratios	RGEN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Arvinas Inc	13.49	$ 316.700 Millions	$ 23.475 Millions
Rosecliff Acquisition Corp I	13.43	$ 16.467 Millions	$ 1.226 Millions
Corcept Therapeutics Inc	13.30	$ 830.813 Millions	$ 62.477 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Skinhealth Systems Inc	13.04	$ 289.224 Millions	$ 22.179 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.82	$ 8.855 Millions	$ 0.749 Millions
Marpai Inc	11.71	$ 16.635 Millions	$ 1.420 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions
Immucell Corporation	10.29	$ 29.777 Millions	$ 2.893 Millions
Addus Homecare Corp	10.23	$ 1,475.610 Millions	$ 144.195 Millions
Dariohealth Corp	10.23	$ 21.196 Millions	$ 2.072 Millions
Radnet Inc	10.11	$ 2,268.932 Millions	$ 224.447 Millions
Utah Medical Products Inc	9.88	$ 35.679 Millions	$ 3.612 Millions
Lensar Inc	9.75	$ 60.264 Millions	$ 6.184 Millions
Biolife Solutions Inc	9.67	$ 102.718 Millions	$ 10.626 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
The Oncology Institute Inc	9.57	$ 587.244 Millions	$ 61.364 Millions
Alumis inc	9.44	$ 7.398 Millions	$ 0.784 Millions

Date modified: 2026-08-12T20:46:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.